Ioana Hotea

Extra informatie

Bijzondere interesses:
Kristalartritis (jicht, CPPD)

Behaalde certificaten / publicaties / bijscholingen:

Badii, M.; Gaal, O.I.; Hotea, I.; Nica, V.; Mirea, A.M.; Mărginean, D.; HINT Consortium; Pamfil, C.; Rednic, S.; Popp, R.A.; et al. Sex-Specific Differences in Cytokine Production Capacity in Patients with Gout Compared to Controls. Gout Urate Cryst. Depos. Dis. 2024, 2, 133-143. https://doi.org/10.3390/gucdd2020012

Hotea, I., Janssen, M., & Jansen, T. L.  Lessons to be learned from real life data from 98 gout patients using a uricosuric: Benzbromarone. Exploration of Musculoskeletal Diseases. https://doi.org/10.37349/emd.2023.00019

Hotea, I., Giesen, T., Comarniceanu, A., Efde, M., Van Osch, F., Janssen, M., & Jansen, T. L. (2023). Real-life results of urate-driven pharmacotherapy with three urate lowering drugs in gout: Allopurinol, febuxostat and benzbromarone. Exploration of Musculoskeletal Diseases, 97–105. https://doi.org/10.37349/emd.2023.00014

Cabau, G., Gaal, O., Badii, M., Nica, V., Mirea, A. M., Hotea, I., HINT Consortium, Pamfil, C., Popp, R. A., Netea, M. G., Rednic, S., Crisan, T. O., & Joosten, L. A. B. (2023). Hyperuricemia remodels the serum proteome toward a higher inflammatory state [Preprint]. SSRN. https://doi.org/10.2139/ssrn.4492078

Jansen, T. L. T. A., Hotea, I., & le Noble, J. L. (2021). Severe Covid-19 is a Risk Factor for Gout Even in Hypouricaemic ICU Patients. Sign of Arousal of NLRP3 Activation? EC Orthopaedics, 12(7), 33–38.

Kampe, R. T., Nielsen, S. M., Hotea, I., Van Durme, C., Christensen, R., & Boonen, A. (2022). Effect modification by contextual factors of urate- lowering therapy on serum urate in people with gout: A systematic review with meta-regression analysis. Seminars in Arthritis and Rheumatism, 56, 152049. https://doi.org/10.1016/j.semarthrit.2022.152049

Certificaten:

EULAR Online Introductory Ultrasound Course 2024

Crystal identification in polarized light microscopy-ACR ATLANTA VS

Raadpleging op afspraak